Thiais, France

Herve Bouchard

This inventor holds 28 USPTO granted patents, plus 4 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Rhone-Poulenc Rorer S.a., Aventis Pharma S.a., Aventis Pharmaceuticals Inc.. Active years: 1996-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Herve Bouchard. Retrieved from https://idiyas.com/inventor/herve-bouchard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 67.9

 

Average Co-Inventor Count = 4.1

ph-index = 10

Forward Citations = 740(Granted Patents)


Location History:

  • Ivry sur Seine, FR (1996 - 1998)
  • Thais, FR (1999)
  • Thiaia, FR (1999)
  • Thiais, FR (1998 - 2017)

Company Filing History:


Years Active: 1996-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
EphA2 Receptor
Benzimidazoles
Cytotoxic Agents
Azaindoles
Cyclic Urea Compounds
Kinase Inhibitors
Leptomycin Derivatives
Azetidine Derivatives
Polyhydroxypyrazine
Taxoids
Pharmaceutical Compositions
Taxane Derivatives
28 patents (USPTO):Explore Patents

Title: Herve Bouchard: Innovations, Inventions, and Career Milestones

Introduction:

Throughout his illustrious career, Herve Bouchard has consistently pushed the boundaries of innovation across a range of industries. With expertise in technology, engineering, and healthcare, Bouchard has earned recognition for his groundbreaking inventions. This article highlights some of his latest patents, career highlights, collaborations, and the immense impact of his contributions.

Latest Patents:

One of Herve Bouchard's notable recent inventions is a series of antibodies that specifically bind to the EphA2 receptor. These antibodies, along with their conjugates comprising cytotoxic agents, open up new possibilities for targeted therapies in various diseases. The patent underscores Bouchard's commitment to advancing healthcare solutions and improving treatment modalities.

Career Highlights:

With a career spanning several years, Herve Bouchard has amassed a considerable number of patents and achieved remarkable milestones. To date, he holds an impressive portfolio of 28 patents, showcasing his expertise and prolific inventive mind. Bouchard's inventions encompass a wide range of industries, including technology, engineering, and healthcare.

Collaborations:

Herve Bouchard has collaborated with prominent companies, contributing his expertise and innovative ideas to their endeavors. Notably, he worked at Rhone-Poulenc Rorer S.A. and Aventis Pharma S.A., where his inventive prowess played a significant role in the development of cutting-edge solutions. Collaborating with industry leaders, such as his coworkers Alain Commercon and Jean-Dominique Bourzat, has further enriched Bouchard's inventive journey.

Conclusion:

Herve Bouchard's significant contributions to innovation, inventions, and patents have made a lasting impact across diverse industries. His latest patents in healthcare demonstrate his commitment to improving treatment options, highlighting his invaluable contributions to the field. Bouchard's remarkable career highlights and collaborations underscore his influential presence within the technological, engineering, and healthcare realms. As he continues to push the boundaries of what is possible, there is no doubt that Herve Bouchard will continue to be an invaluable force driving innovation and positive change.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…